Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

Proteomics

Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

Featured Speaker: Naval Daver, PhD, Associate Professor, Department of Leukemia, MD Anderson Cancer Center

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy

Explore relevant biomarker strategies associated with these approaches

See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival

Explore Related Resources

Access related webinars, eBooks, app notes & case studies.

Webinar

Single-Cell Polyfunctional Strength Applied to Checkpoint & Antibody Based Immunotherapies

Blog

Checkpoint Immunotherapy in Solid Tumor Is Evolving: Advancing Cellular Fitness & Precision Medicine with IsoPlexis’ Platform

Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Watch the Webinar

Back to the Top